Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Acta Dermato-Venereologica|January 1, 1985
Pityriasis rosea (Gibert): abnormal distribution pattern of antigen presenting cells in situJ D Bos, P M Huisman, S R Krieg, et al.Clinical and Experimental Immunology|January 1, 1979
A placebo controlled clinical trial of transfer factor in lepromatous leprosyW R Faber, D L Leiker, I M Nengerman, et al.FEMS Immunology and Medical Microbiology|January 5, 2000
Serum neopterin concentrations during treatment of leishmaniasis: useful as test of cure?F F Hamerlinck, T van Gool, W R Faber, et al.Nederlands Tijdschrift Voor Geneeskunde|May 2, 2007
[Contributions of the Netherlands and its colonies to the knowledge of the cause of leprosy in the 19th century]H E Menke, R J B Wille, W R Faber, et al.Nederlands Tijdschrift Voor Geneeskunde|April 2, 2004
[Cutaneous nocardiosis as an opportunistic infection]H J Bogaard, G W Erkelens, W R Faber, et al.Clinical and Experimental Dermatology|December 17, 2008
Cutaneous leishmaniasis with lymphadenopathy due to Leishmania donovaniW R Faber, J Wonders, A J Jensema, et al.Medicina Cutanea Ibero-Latino-Americana|January 1, 1987
[Ito's hypomelanosis]R M Pujol, A Ravella, A Alomar, et al.Nederlands Tijdschrift Voor Geneeskunde|September 24, 1994
[Leprosy in The Netherlands in the period 1970-1991]E Post, R A chin-A-Lien, C Bouman, et al.VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
Local treatment of venous ulcers with tissue type plasminogen activator containing ointmentJ E Zeegelaar, J H Verheijen, J A Kerckhaert, et al.VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1992
Immunofluorescence studies of atrophie blanche with antibodies against fibrinogen, fibrin, plasminogen activator inhibitor, factor VIII-related antigen, and collagen type IVM Brakman, W R Faber, J A Kerckhaert, et al.Pageof 8